 | • レポートコード：MRC2-11QY11435 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は大腸がん診断のグローバル市場について調査・分析したレポートです。種類別（便潜血検査、バイオマーカー検査、CRCDNAスクリーニング検査）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別大腸がん診断の競争状況、市場シェア ・世界の大腸がん診断市場：種類別市場規模 2015年-2020年（便潜血検査、バイオマーカー検査、CRCDNAスクリーニング検査） ・世界の大腸がん診断市場：種類別市場規模予測 2021年-2026年（便潜血検査、バイオマーカー検査、CRCDNAスクリーニング検査） ・世界の大腸がん診断市場：用途別市場規模 2015年-2020年（病院、外来手術センター、診断センター） ・世界の大腸がん診断市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、診断センター） ・北米の大腸がん診断市場分析：米国、カナダ ・ヨーロッパの大腸がん診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの大腸がん診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の大腸がん診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの大腸がん診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Molecular、Abbott、Beckman Coulter、Eiken Chemical、Epigenomics、Sysmex、Siemens Healthcare、Quest Diagnostics、CompanianDx、BioTime、Merck Millipore、GeneNews、BioMarCare、Immunostics、ExiQon、Mode Diagnostics、Randox、R-Biopharm ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Fecal occult blood tests dominated the industry in 2016 owing to cost effectiveness and non-invasiveness as compared to colonoscopy and sigmoidoscopy. Immuno-FOB agglutination and Immuno-FOB ELISA tests are major revenue generating segments of fecal occult blood tests segment. Growing awareness along with rising demand for non-invasive cancer screening tests will further fuel business growth.
Increasing incidences of colorectal cancer coupled with rising demand for non-invasive cancer screening tests will drive in-vitro colorectal cancer screening tests market over the forecast period. Growing geriatric population base, highly susceptible to suffer from colorectal cancer will further propel market growth.
Market Analysis and Insights: Global Colorectal Cancer Diagnostic Market
The global Colorectal Cancer Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Colorectal Cancer Diagnostic Scope and Market Size
Colorectal Cancer Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Molecular
Abbott
Beckman Coulter
Eiken Chemical
Epigenomics
Sysmex
Siemens Healthcare
Quest Diagnostics
CompanianDx
BioTime
Merck Millipore
GeneNews
BioMarCare
Immunostics
ExiQon
Mode Diagnostics
Randox
R-Biopharm
Market segment by Type, the product can be split into
Fecal Occult Blood Test
Biomarker Test
CRC DNA Screening Test
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Colorectal Cancer Diagnostic Revenue
1.4 Market by Type
1.4.1 Global Colorectal Cancer Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Fecal Occult Blood Test
1.4.3 Biomarker Test
1.4.4 CRC DNA Screening Test
1.5 Market by Application
1.5.1 Global Colorectal Cancer Diagnostic Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Diagnostic Market Perspective (2015-2026)
2.2 Global Colorectal Cancer Diagnostic Growth Trends by Regions
2.2.1 Colorectal Cancer Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Colorectal Cancer Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 Colorectal Cancer Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Colorectal Cancer Diagnostic Market Growth Strategy
2.3.6 Primary Interviews with Key Colorectal Cancer Diagnostic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Diagnostic Players by Market Size
3.1.1 Global Top Colorectal Cancer Diagnostic Players by Revenue (2015-2020)
3.1.2 Global Colorectal Cancer Diagnostic Revenue Market Share by Players (2015-2020)
3.1.3 Global Colorectal Cancer Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Colorectal Cancer Diagnostic Market Concentration Ratio
3.2.1 Global Colorectal Cancer Diagnostic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostic Revenue in 2019
3.3 Colorectal Cancer Diagnostic Key Players Head office and Area Served
3.4 Key Players Colorectal Cancer Diagnostic Product Solution and Service
3.5 Date of Enter into Colorectal Cancer Diagnostic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Colorectal Cancer Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global Colorectal Cancer Diagnostic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Colorectal Cancer Diagnostic Market Size by Application (2015-2020)
5.2 Global Colorectal Cancer Diagnostic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Colorectal Cancer Diagnostic Market Size (2015-2020)
6.2 Colorectal Cancer Diagnostic Key Players in North America (2019-2020)
6.3 North America Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
6.4 North America Colorectal Cancer Diagnostic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Colorectal Cancer Diagnostic Market Size (2015-2020)
7.2 Colorectal Cancer Diagnostic Key Players in Europe (2019-2020)
7.3 Europe Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
7.4 Europe Colorectal Cancer Diagnostic Market Size by Application (2015-2020)
8 China
8.1 China Colorectal Cancer Diagnostic Market Size (2015-2020)
8.2 Colorectal Cancer Diagnostic Key Players in China (2019-2020)
8.3 China Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
8.4 China Colorectal Cancer Diagnostic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Colorectal Cancer Diagnostic Market Size (2015-2020)
9.2 Colorectal Cancer Diagnostic Key Players in Japan (2019-2020)
9.3 Japan Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
9.4 Japan Colorectal Cancer Diagnostic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Colorectal Cancer Diagnostic Market Size (2015-2020)
10.2 Colorectal Cancer Diagnostic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
10.4 Southeast Asia Colorectal Cancer Diagnostic Market Size by Application (2015-2020)
11 India
11.1 India Colorectal Cancer Diagnostic Market Size (2015-2020)
11.2 Colorectal Cancer Diagnostic Key Players in India (2019-2020)
11.3 India Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
11.4 India Colorectal Cancer Diagnostic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Colorectal Cancer Diagnostic Market Size (2015-2020)
12.2 Colorectal Cancer Diagnostic Key Players in Central & South America (2019-2020)
12.3 Central & South America Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
12.4 Central & South America Colorectal Cancer Diagnostic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Molecular
13.1.1 Abbott Molecular Company Details
13.1.2 Abbott Molecular Business Overview
13.1.3 Abbott Molecular Colorectal Cancer Diagnostic Introduction
13.1.4 Abbott Molecular Revenue in Colorectal Cancer Diagnostic Business (2015-2020))
13.1.5 Abbott Molecular Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Colorectal Cancer Diagnostic Introduction
13.2.4 Abbott Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Beckman Coulter
13.3.1 Beckman Coulter Company Details
13.3.2 Beckman Coulter Business Overview
13.3.3 Beckman Coulter Colorectal Cancer Diagnostic Introduction
13.3.4 Beckman Coulter Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
13.3.5 Beckman Coulter Recent Development
13.4 Eiken Chemical
13.4.1 Eiken Chemical Company Details
13.4.2 Eiken Chemical Business Overview
13.4.3 Eiken Chemical Colorectal Cancer Diagnostic Introduction
13.4.4 Eiken Chemical Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
13.4.5 Eiken Chemical Recent Development
13.5 Epigenomics
13.5.1 Epigenomics Company Details
13.5.2 Epigenomics Business Overview
13.5.3 Epigenomics Colorectal Cancer Diagnostic Introduction
13.5.4 Epigenomics Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
13.5.5 Epigenomics Recent Development
13.6 Sysmex
13.6.1 Sysmex Company Details
13.6.2 Sysmex Business Overview
13.6.3 Sysmex Colorectal Cancer Diagnostic Introduction
13.6.4 Sysmex Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
13.6.5 Sysmex Recent Development
13.7 Siemens Healthcare
13.7.1 Siemens Healthcare Company Details
13.7.2 Siemens Healthcare Business Overview
13.7.3 Siemens Healthcare Colorectal Cancer Diagnostic Introduction
13.7.4 Siemens Healthcare Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
13.7.5 Siemens Healthcare Recent Development
13.8 Quest Diagnostics
13.8.1 Quest Diagnostics Company Details
13.8.2 Quest Diagnostics Business Overview
13.8.3 Quest Diagnostics Colorectal Cancer Diagnostic Introduction
13.8.4 Quest Diagnostics Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
13.8.5 Quest Diagnostics Recent Development
13.9 CompanianDx
13.9.1 CompanianDx Company Details
13.9.2 CompanianDx Business Overview
13.9.3 CompanianDx Colorectal Cancer Diagnostic Introduction
13.9.4 CompanianDx Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
13.9.5 CompanianDx Recent Development
13.10 BioTime
13.10.1 BioTime Company Details
13.10.2 BioTime Business Overview
13.10.3 BioTime Colorectal Cancer Diagnostic Introduction
13.10.4 BioTime Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
13.10.5 BioTime Recent Development
13.11 Merck Millipore
10.11.1 Merck Millipore Company Details
10.11.2 Merck Millipore Business Overview
10.11.3 Merck Millipore Colorectal Cancer Diagnostic Introduction
10.11.4 Merck Millipore Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
10.11.5 Merck Millipore Recent Development
13.12 GeneNews
10.12.1 GeneNews Company Details
10.12.2 GeneNews Business Overview
10.12.3 GeneNews Colorectal Cancer Diagnostic Introduction
10.12.4 GeneNews Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
10.12.5 GeneNews Recent Development
13.13 BioMarCare
10.13.1 BioMarCare Company Details
10.13.2 BioMarCare Business Overview
10.13.3 BioMarCare Colorectal Cancer Diagnostic Introduction
10.13.4 BioMarCare Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
10.13.5 BioMarCare Recent Development
13.14 Immunostics
10.14.1 Immunostics Company Details
10.14.2 Immunostics Business Overview
10.14.3 Immunostics Colorectal Cancer Diagnostic Introduction
10.14.4 Immunostics Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
10.14.5 Immunostics Recent Development
13.15 ExiQon
10.15.1 ExiQon Company Details
10.15.2 ExiQon Business Overview
10.15.3 ExiQon Colorectal Cancer Diagnostic Introduction
10.15.4 ExiQon Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
10.15.5 ExiQon Recent Development
13.16 Mode Diagnostics
10.16.1 Mode Diagnostics Company Details
10.16.2 Mode Diagnostics Business Overview
10.16.3 Mode Diagnostics Colorectal Cancer Diagnostic Introduction
10.16.4 Mode Diagnostics Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
10.16.5 Mode Diagnostics Recent Development
13.17 Randox
10.17.1 Randox Company Details
10.17.2 Randox Business Overview
10.17.3 Randox Colorectal Cancer Diagnostic Introduction
10.17.4 Randox Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
10.17.5 Randox Recent Development
13.18 R-Biopharm
10.18.1 R-Biopharm Company Details
10.18.2 R-Biopharm Business Overview
10.18.3 R-Biopharm Colorectal Cancer Diagnostic Introduction
10.18.4 R-Biopharm Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
10.18.5 R-Biopharm Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Colorectal Cancer Diagnostic Key Market Segments
Table 2. Key Players Covered: Ranking by Colorectal Cancer Diagnostic Revenue
Table 3. Ranking of Global Top Colorectal Cancer Diagnostic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Colorectal Cancer Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fecal Occult Blood Test
Table 6. Key Players of Biomarker Test
Table 7. Key Players of CRC DNA Screening Test
Table 8. Global Colorectal Cancer Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Colorectal Cancer Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Colorectal Cancer Diagnostic Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Colorectal Cancer Diagnostic Market Share by Regions (2015-2020)
Table 12. Global Colorectal Cancer Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Colorectal Cancer Diagnostic Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Colorectal Cancer Diagnostic Market Growth Strategy
Table 18. Main Points Interviewed from Key Colorectal Cancer Diagnostic Players
Table 19. Global Colorectal Cancer Diagnostic Revenue by Players (2015-2020) (Million US$)
Table 20. Global Colorectal Cancer Diagnostic Market Share by Players (2015-2020)
Table 21. Global Top Colorectal Cancer Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnostic as of 2019)
Table 22. Global Colorectal Cancer Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Colorectal Cancer Diagnostic Product Solution and Service
Table 25. Date of Enter into Colorectal Cancer Diagnostic Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Colorectal Cancer Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 28. Global Colorectal Cancer Diagnostic Market Size Share by Type (2015-2020)
Table 29. Global Colorectal Cancer Diagnostic Revenue Market Share by Type (2021-2026)
Table 30. Global Colorectal Cancer Diagnostic Market Size Share by Application (2015-2020)
Table 31. Global Colorectal Cancer Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 32. Global Colorectal Cancer Diagnostic Market Size Share by Application (2021-2026)
Table 33. North America Key Players Colorectal Cancer Diagnostic Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Colorectal Cancer Diagnostic Market Share (2019-2020)
Table 35. North America Colorectal Cancer Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 36. North America Colorectal Cancer Diagnostic Market Share by Type (2015-2020)
Table 37. North America Colorectal Cancer Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 38. North America Colorectal Cancer Diagnostic Market Share by Application (2015-2020)
Table 39. Europe Key Players Colorectal Cancer Diagnostic Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Colorectal Cancer Diagnostic Market Share (2019-2020)
Table 41. Europe Colorectal Cancer Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Colorectal Cancer Diagnostic Market Share by Type (2015-2020)
Table 43. Europe Colorectal Cancer Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Colorectal Cancer Diagnostic Market Share by Application (2015-2020)
Table 45. China Key Players Colorectal Cancer Diagnostic Revenue (2019-2020) (Million US$)
Table 46. China Key Players Colorectal Cancer Diagnostic Market Share (2019-2020)
Table 47. China Colorectal Cancer Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 48. China Colorectal Cancer Diagnostic Market Share by Type (2015-2020)
Table 49. China Colorectal Cancer Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 50. China Colorectal Cancer Diagnostic Market Share by Application (2015-2020)
Table 51. Japan Key Players Colorectal Cancer Diagnostic Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Colorectal Cancer Diagnostic Market Share (2019-2020)
Table 53. Japan Colorectal Cancer Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Colorectal Cancer Diagnostic Market Share by Type (2015-2020)
Table 55. Japan Colorectal Cancer Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Colorectal Cancer Diagnostic Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Colorectal Cancer Diagnostic Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Colorectal Cancer Diagnostic Market Share (2019-2020)
Table 59. Southeast Asia Colorectal Cancer Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Colorectal Cancer Diagnostic Market Share by Type (2015-2020)
Table 61. Southeast Asia Colorectal Cancer Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Colorectal Cancer Diagnostic Market Share by Application (2015-2020)
Table 63. India Key Players Colorectal Cancer Diagnostic Revenue (2019-2020) (Million US$)
Table 64. India Key Players Colorectal Cancer Diagnostic Market Share (2019-2020)
Table 65. India Colorectal Cancer Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 66. India Colorectal Cancer Diagnostic Market Share by Type (2015-2020)
Table 67. India Colorectal Cancer Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 68. India Colorectal Cancer Diagnostic Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Colorectal Cancer Diagnostic Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Colorectal Cancer Diagnostic Market Share (2019-2020)
Table 71. Central & South America Colorectal Cancer Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Colorectal Cancer Diagnostic Market Share by Type (2015-2020)
Table 73. Central & South America Colorectal Cancer Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Colorectal Cancer Diagnostic Market Share by Application (2015-2020)
Table 75. Abbott Molecular Company Details
Table 76. Abbott Molecular Business Overview
Table 77. Abbott Molecular Product
Table 78. Abbott Molecular Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 79. Abbott Molecular Recent Development
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Beckman Coulter Company Details
Table 86. Beckman Coulter Business Overview
Table 87. Beckman Coulter Product
Table 88. Beckman Coulter Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 89. Beckman Coulter Recent Development
Table 90. Eiken Chemical Company Details
Table 91. Eiken Chemical Business Overview
Table 92. Eiken Chemical Product
Table 93. Eiken Chemical Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 94. Eiken Chemical Recent Development
Table 95. Epigenomics Company Details
Table 96. Epigenomics Business Overview
Table 97. Epigenomics Product
Table 98. Epigenomics Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 99. Epigenomics Recent Development
Table 100. Sysmex Company Details
Table 101. Sysmex Business Overview
Table 102. Sysmex Product
Table 103. Sysmex Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 104. Sysmex Recent Development
Table 105. Siemens Healthcare Company Details
Table 106. Siemens Healthcare Business Overview
Table 107. Siemens Healthcare Product
Table 108. Siemens Healthcare Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 109. Siemens Healthcare Recent Development
Table 110. Quest Diagnostics Business Overview
Table 111. Quest Diagnostics Product
Table 112. Quest Diagnostics Company Details
Table 113. Quest Diagnostics Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 114. Quest Diagnostics Recent Development
Table 115. CompanianDx Company Details
Table 116. CompanianDx Business Overview
Table 117. CompanianDx Product
Table 118. CompanianDx Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 119. CompanianDx Recent Development
Table 120. BioTime Company Details
Table 121. BioTime Business Overview
Table 122. BioTime Product
Table 123. BioTime Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 124. BioTime Recent Development
Table 125. Merck Millipore Company Details
Table 126. Merck Millipore Business Overview
Table 127. Merck Millipore Product
Table 128. Merck Millipore Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 129. Merck Millipore Recent Development
Table 130. GeneNews Company Details
Table 131. GeneNews Business Overview
Table 132. GeneNews Product
Table 133. GeneNews Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 134. GeneNews Recent Development
Table 135. BioMarCare Company Details
Table 136. BioMarCare Business Overview
Table 137. BioMarCare Product
Table 138. BioMarCare Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 139. BioMarCare Recent Development
Table 140. Immunostics Company Details
Table 141. Immunostics Business Overview
Table 142. Immunostics Product
Table 143. Immunostics Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 144. Immunostics Recent Development
Table 145. ExiQon Company Details
Table 146. ExiQon Business Overview
Table 147. ExiQon Product
Table 148. ExiQon Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 149. ExiQon Recent Development
Table 150. Mode Diagnostics Company Details
Table 151. Mode Diagnostics Business Overview
Table 152. Mode Diagnostics Product
Table 153. Mode Diagnostics Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 154. Mode Diagnostics Recent Development
Table 155. Randox Company Details
Table 156. Randox Business Overview
Table 157. Randox Product
Table 158. Randox Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 159. Randox Recent Development
Table 160. R-Biopharm Company Details
Table 161. R-Biopharm Business Overview
Table 162. R-Biopharm Product
Table 163. R-Biopharm Revenue in Colorectal Cancer Diagnostic Business (2015-2020) (Million US$)
Table 164. R-Biopharm Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Diagnostic Market Share by Type: 2020 VS 2026
Figure 2. Fecal Occult Blood Test Features
Figure 3. Biomarker Test Features
Figure 4. CRC DNA Screening Test Features
Figure 5. Global Colorectal Cancer Diagnostic Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Colorectal Cancer Diagnostic Report Years Considered
Figure 10. Global Colorectal Cancer Diagnostic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Colorectal Cancer Diagnostic Market Share by Regions: 2020 VS 2026
Figure 12. Global Colorectal Cancer Diagnostic Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Colorectal Cancer Diagnostic Market Share by Players in 2019
Figure 15. Global Top Colorectal Cancer Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnostic as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Colorectal Cancer Diagnostic Revenue in 2019
Figure 17. North America Colorectal Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Colorectal Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Colorectal Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Colorectal Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Colorectal Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Colorectal Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Colorectal Cancer Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
子宮頸がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Diagnostic Test Market The global Cervical Cancer Diagnostic Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…- 肝炎診断検査の世界市場（～2026年） Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period.…
- 大腸がん診断・治療の世界市場（～2026年） Colorectal cancer is the development of cancer from the colonor rectum. The main market drivers are increasing cancer prevention initiatives, technological advancements in radiology and chemotherapy, and increasing incidence and prevalence of colorectal cancer. Market Analysis and Insights: Global C…
- 子宮がん診断検査の世界市場（～2026年） Uterus a female organ also referred as the womb is located in the lower abdomen. It supports in the fetal development until birth. In North America, the U.S. is expected to be the dominant market for uterine cancer diagnostic testing due to growing incidence of uterine cancer. Market Analysis and In…
- 転移性大腸癌手術の世界市場（～2026年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…